Models of gouty nephropathy: exploring disease mechanisms and identifying potential therapeutic targets

Front Med (Lausanne). 2024 Feb 29:11:1305431. doi: 10.3389/fmed.2024.1305431. eCollection 2024.

Abstract

Gouty nephropathy (GN) is a metabolic disease with persistently elevated blood uric acid levels. The main manifestations of GN are crystalline kidney stones, chronic interstitial nephritis, and renal fibrosis. Understanding the mechanism of the occurrence and development of GN is crucial to the development of new drugs for prevention and treatment of GN. Currently, most studies exploring the pathogenesis of GN are primarily based on animal and cell models. Numerous studies have shown that inflammation, oxidative stress, and programmed cell death mediated by uric acid and sodium urate are involved in the pathogenesis of GN. In this article, we first review the mechanisms underlying the abnormal intrinsic immune activation and programmed cell death in GN and then describe the characteristics and methods used to develop animal and cell models of GN caused by elevated uric acid and deposited sodium urate crystals. Finally, we propose potential animal models for GN caused by abnormally high uric acid levels, thereby provide a reference for further investigating the methods and mechanisms of GN and developing better prevention and treatment strategies.

Keywords: animal models; cell model; gouty nephropathy; pathogenesis; uric acid.

Publication types

  • Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the National Natural Science Foundation of China (82260925), Yunnan Basic Research Program Youth Project (202201AU070164), Joint Special General Project of Yunnan Provincial Department of Science and Technology and Yunnan University of Traditional Chinese Medicine on Applied Basic Research (202101AZ070001-241 and 202101AZ070001-018), Yunnan Province Major Science and Technology Plan Biomedical Special Project (202102AA310006), Yunnan Province Traditional Chinese Medicine Prevention and Treatment of Bi Disease (Rheumatology) Innovation Team (202305AS350007), and Joint General Program of Traditional Chinese Medicine (11370101874).